Beta Loc
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Beta Loc as PDF for free.
More details
- Words: 311
- Pages: 3
Brand Name: Apo- Metoprolol, Betaloc, Lopressor, Novometropol Generic Name: Metoprolol Indications: PO: used alone or in combination with other agents in the treatment of Hypertension and Angina Pectoris PO, IV: Prevention of Myocardial Infarction. Unlabeled Uses: Prophylaxis and Treatment of Arrhythmias Treatment of Hypertonic Cardiomyopathy Mitral Valve Prolapse Tremors Symptomatic Treatment of Pheochromocytoma Prevention of Vascular Headache Management of Aggressive Behavior Drug Classification: Antihypertensive – Beta-adrenergic blocker, Antianginal, Betaadrenergic blocker - selective Mechanism of Action: Blocks stimulation of Beta1 adrenergic receptors with less effect on Beta2 receptor sites
Dosage: Chronic treatment of hypertension, Angina; Myocardial Infarction Prophylaxis: PO (Adults): 100-450 mg/day – single dose or bid. Myocardial Infarction Prophylaxis – Acute Treatment IV (Adults): 5mg q 2 min for 3 doses. Special Precaution: Pregnancy; Hyperthyroidism; Diabetes Mellitus; Lactation or Children Pregnancy Risk Category: B Adverse Reactions: CNS: Fatigue, Weakness, Dizziness, Depression, Memory Loss, Mental Changes, Nightmares EENT: Blurred Vision Resp: Bronchospasm, Wheezing CV: Bradycardia, Congestive Heart Failure, Pulmonary Edema, Peripheral Vasoconstriction GI: Constipation, Diarrhea, Nausea GU: Impotence, Diminished Libido Endo: Hyperglycemia, Hypoglycemia Contraindications: Uncompensated Congestive Heart Failure; Pulmonary Edema; Cardiogenic Shock; Bradycardia or Heart Block
(continuation Apo- Metoprolol, Betaloc, Lopressor, Novometropol) Form: Tab 10mg x 100’s; 50mg x 100’s; 500’s Nursing Responsibilities: General Info: monitor intake and output ratios and daily weight. Assess patient routinely for evidence of fluid overload Hypertension: Monitor blood pressure and pulse frequently during period of adjustment and periodically throughout therapy. Confer with physician prior to giving drug if pulse is <50 bpm. Vital signs and ECG should be monitored every 5-15mins during and for several hrs after parental administration. Angina: Assess frequency and duration of episodes of chest pain throughout therapy. Lab Test Considerations: May occasionally cause elevations in Potassium, Uric Acid, Lipoprotein Levels, and BUN. Hepatic and renal function and CBC should be monitored periodically in patients receiving prolonged therapy.
Dosage: Chronic treatment of hypertension, Angina; Myocardial Infarction Prophylaxis: PO (Adults): 100-450 mg/day – single dose or bid. Myocardial Infarction Prophylaxis – Acute Treatment IV (Adults): 5mg q 2 min for 3 doses. Special Precaution: Pregnancy; Hyperthyroidism; Diabetes Mellitus; Lactation or Children Pregnancy Risk Category: B Adverse Reactions: CNS: Fatigue, Weakness, Dizziness, Depression, Memory Loss, Mental Changes, Nightmares EENT: Blurred Vision Resp: Bronchospasm, Wheezing CV: Bradycardia, Congestive Heart Failure, Pulmonary Edema, Peripheral Vasoconstriction GI: Constipation, Diarrhea, Nausea GU: Impotence, Diminished Libido Endo: Hyperglycemia, Hypoglycemia Contraindications: Uncompensated Congestive Heart Failure; Pulmonary Edema; Cardiogenic Shock; Bradycardia or Heart Block
(continuation Apo- Metoprolol, Betaloc, Lopressor, Novometropol) Form: Tab 10mg x 100’s; 50mg x 100’s; 500’s Nursing Responsibilities: General Info: monitor intake and output ratios and daily weight. Assess patient routinely for evidence of fluid overload Hypertension: Monitor blood pressure and pulse frequently during period of adjustment and periodically throughout therapy. Confer with physician prior to giving drug if pulse is <50 bpm. Vital signs and ECG should be monitored every 5-15mins during and for several hrs after parental administration. Angina: Assess frequency and duration of episodes of chest pain throughout therapy. Lab Test Considerations: May occasionally cause elevations in Potassium, Uric Acid, Lipoprotein Levels, and BUN. Hepatic and renal function and CBC should be monitored periodically in patients receiving prolonged therapy.
